Respiratory distress syndrome (RDS)

Respiratory

Respiratory distress syndrome is the poster child for neonatology

Introduction My goal is to discuss the significant improvement in mortality rates for respiratory distress syndrome (RDS) due to new therapies. In the 1950s and 1960s, mortality rates were approximately 50% (Fig. 1); however, with the introduction of CPAP, surfactant therapy, antenatal steroids, and mechanical ventilation, today’s mortality rate has dropped to less than 2%. This […]

, ,

Respiratory distress syndrome is the poster child for neonatology Read Post »

Respiratory

Understanding ventilator-induced lung injury: The role of mechanical power

Abstract Mechanical ventilation stands as a life-saving intervention in the management of respiratory failure. However, it carries the risk of ventilator-induced lung injury. Despite the adoption of lung-protective ventilation strategies, including lower tidal volumes and pressure limitations, mortality rates remain high, leaving room for innovative approaches. The concept of mechanical power has emerged as a

, , , ,

Understanding ventilator-induced lung injury: The role of mechanical power Read Post »

Respiratory

Effectiveness of antenatal dexamethasone in reducing respiratory distress syndrome and mortality in preterm neonates: a nested case control study

Abstract   Background Respiratory distress syndrome (RDS) is a significant cause of preterm neonatal morbidity and mortality globally. Measures like the use of antenatal corticosteroids (ACS) and immediate resuscitation of the newborn after birth are taken to abate preterm related complications. Most studies that evidenced the benefit of ACS were done in high resource settings.

, ,

Effectiveness of antenatal dexamethasone in reducing respiratory distress syndrome and mortality in preterm neonates: a nested case control study Read Post »

Scroll to Top